· 14 min
Peter Diamandis: "AGI Is Already Here - They Just Haven't Released It Yet"
What if the Singularity isn’t coming but already here?
Explore conversation4 December 2025 · 75 min
With Jonathan Anomaly · Hosted by Julian Issa
What happens when the future of humanity is no longer something we wait for but something we can choose?
JUMP INTO THE CONVERSATION
What happens when the future of humanity is no longer something we wait for but something we can choose?
When science gives us that kind of power, the real question becomes how wisely we’re prepared to use it. Today, Jonathan joins Julian to break down the fast-evolving world of embryo selection and what it could mean for the future of human evolution. Jonathan explains how IVF has grown from a niche medical procedure into a window into chromosomal health, genetic risk, and now polygenic traits that influence everything from disease risk to intelligence. They also revisit the history of eugenics, unpack the huge difference between past state-controlled abuses and today’s individual, non-coercive choices, and show why modern genomic tools aren’t about “playing God” but about making more informed, thoughtful decisions rooted in science.
What traits should families even care about? How do we keep individuality alive when selection becomes easier? And what happens when science, politics, and markets start overlapping in ways society isn’t quite prepared for? Julian and Jonathan dig into the complexity behind intelligence, personality, mental health, and moral behavior, while also touching on industry controversies, regulation challenges, and the importance of transparency in genetic prediction.
· 14 min
What if the Singularity isn’t coming but already here?
Explore conversation· 63 min
Can AI help us defeat aging or are we still missing the pieces that matter most?
Explore conversation· 51 min
Joe Betts-LaCroix and Retro Biosciences recently raised funding at a $1.8 billion valuation. In his first podcast appearance since the announcement, Joe shares his vision for extending healthy human lifespan and the breakthroughs driving the longevity industry forward.
Explore conversation